Conference on Nutrition and IBD
“An IBD Diet: Is there such a thing?”
FREE webinar
7pm (EST) on September 29, 2021
To join the webinar on the evening of September 29, simply click on the button below or use the link sent to you by email.
An IBD Diet: Is there such a thing? This is the first question of every new (and old) patient: is inflammatory diseases (IBD) related to diet? Can IBD aggravated by food or is there any food that prevents relapses? Most importantly, can diet treat or maintain inflammatory bowel diseases?
This evening is hosted by the McGill IBD Research Group, in collaboration with the Montreal General Hospital Foundation.
Dr. Arie Levine, Professor of Medicine, Director of the Pediatric Gastroenterology and Nutrition Unit, Wolfson Medical Center, in Holon / Southern Tel Aviv, Israel, will discuss the impact of diet on those living with IBD including disease susceptibility, impact on disease course and as a treatment option.
Our Guest Speaker
Dr. Arie Levine is a full professor of pediatrics at Tel Aviv University and is currently the director of the Paediatric Gastroenterology and Nutrition Unit at the Wolfson Medical Center in Holon / Southern Tel Aviv, Israel. He has chaired numerous international IBD committees such as the Porto IBD group, and paediatric ECCO (PECCO), the paediatric committee of the European Crohn’s colitis Organization. He co- founded the diet /nutrition committee of IOIBD. He is an active member of ECCO and IOIBD. He also organized and co- chaired the Paris classification of IBD.
He has proposed novel theories for the pathogenesis of Crohn’s disease and developed novel concepts regarding the role of diet in the pathogenesis of Crohn’s disease and ulcerative colitis. His research unit has spearheaded research in to the development of novel therapies targeting the microbiome including studies to evaluate the use of antibiotics, diet and fecal transplantation in Crohn’s disease and Ulcerative colitis. He has developed two new diets for induction of remission in Crohn’s disease (CDED) and Ulcerative Colitis (UCED) both of which have demonstrated efficacy for induction of remission.
